# ASP Isotopes Inc. (ASPI) — capital_raise/private_placement [pending]
Source: SEC API (secapi.ai) · situation sit_d87cfb73879da1342867 · retrieved 2026-08-11T15:52:28.014Z

## Overview
ASP Isotopes Inc. develops isotope enrichment technologies (Aerodynamic Separation Process and Quantum Enrichment) for nuclear medicine, semiconductors, and nuclear energy; operates enrichment facilities in South Africa and holds a 94.5% stake in Renergen, which produces helium and LNG from the Virginia Gas Project in South Africa.

ASP Isotopes announced a proposed reverse merger of Noble Africa LLC (a subsidiary holding Renergen) with a subsidiary of ENDRA Life Sciences Inc. (Nasdaq: NDRA). The combined company will be renamed Noble Africa Inc. and listed on Nasdaq under ticker "NOBA" as a helium-focused company. Concurrent with the merger, a private placement will raise approximately $50 million gross, including $20 million from ASP Isotopes as lead investor and $30 million from other investors (including $750,000 from ASP directors and management). Upon completion, ASP Isotopes will own approximately 89% of Noble Africa with a free float of approximately 11%. The transactions are expected to close during the second half of 2026, subject to customary closing conditions.

## Terms
- Counterparty: ENDRA Life Sciences Inc. · Deal value: $50.0M · Consideration: cash · Stake: 89%

## Key dates
- Announced 2026-08-04 · Expected close 2026-12-31

## Timeline
- 2026-08-04 · 8-K (0001193125-26-331596): 8-K - ASP Isotopes Inc. — *ASP Isotopes Inc. develops isotope enrichment technologies (Aerodynamic Separation Process and Quantum Enrichment) for nuclear medicine, semiconductors, and nuclear energy; operates enrichment facilities in South Africa and holds a 94.5% stake in Renergen, which produces helium and LNG from the Virginia Gas Project in South Africa.* ASP Isotopes announced a proposed reverse merger of Noble Africa LLC (a subsidiary holding Renergen) with a subsidiary of ENDRA Life Sciences Inc. (Nasdaq: NDRA). The combined company will be renamed Noble Africa Inc. and listed on Nasdaq under ticker "NOBA" as a helium-focused company. Concurrent with the merger, a private placement will raise approximately $50 million gross, including $20 million from ASP Isotopes as lead investor and $30 million from other investors (including $750,000 from ASP directors and management). Upon completion, ASP Isotopes will own approximately 89% of Noble Africa with a free float of approximately 11%. The transactions are expected to close during the second half of 2026, subject to customary closing conditions.
  https://www.sec.gov/Archives/edgar/data/1921865/0001193125-26-331596.txt

## Citations
- 0001193125-26-331596 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526331596